SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: sam who wrote (1048)7/27/1997 12:36:00 AM
From: JOHN W.   of 6136
 
Why would anyone short AGPH in this market? The small share base led to enormous volatility (especially after nelf was approved) which attracted all the parasites with all their tricks, and they made money. Now with approx 3.5 M short with a float of 12M, a handful of people are poised to lose a lot of money. The shorts have become committed buyers. Lehman Brothers changed their Q4 est from a loss of 0.74 to a profit of 0.02, less than a week to the announcement !!! Now their are 8 analyst that rate AGPH a strong buy and 1 that rates it a buy! You can bet there has been a couple of hedge fund manager calling in a few favors. Barrons and the WSJ have indeed had a bias against
AGPH. I find it particularly strange on how Barrons slips whatever companies they want to hit in their "insider transaction" section. Why was AGPH not put in this week's issue, when it still qualifies?
I quite enjoy each Saturday morning to read Alan Abelson's article in Barrons, he has been predicting a market top since the DJIA was at 4000. I remember very clearly when he said the mkt would suffer the worst crash ever at 5000, then again at 6000, at 7000, and is screaming bloody murder today at over 8100. How does a man like this even have a job? Not only to be so wrong, but have the audacity to never admit so. In 2003, when the market falls from 19,000 to 13,000, he will be the first to write "I told you so!". Anticipate a spike in the next 2 weeks (104-115). 140 before X-mas. European approval before X-mas. Just my 14000 cents/share worth.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext